MedTrace Logo

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)

NCT00561730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1995

Last updated 2012-05-08

Study results available
· View outcomes & findings →

Summary

The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DRUG

Pantoprazole

Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily).

Sponsors & Collaborators

  • Nycomed

    lead INDUSTRY

Principal Investigators

  • Dr. Thomas D. Bethke, MD, MBA · Nycomed Deutschland GmbH, 78467 Konstanz, Germany

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561730 on ClinicalTrials.gov